Daniel H. Orenstein Health Catalyst, Inc. (HCAT) insider trading activity

Daniel H. Orenstein is General Counsel of Health Catalyst, Inc.. Currently has a direct ownership of 133,097 shares of HCAT, which is worth approximately $1.12 Million. The most recent transaction as insider was on Aug 02, 2021, when has been sold 2,500 shares (Common Stock) at a price of $10.34 per share, resulting in proceeds of $25,850. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 133K

0% 3M change

0% 12M change

Total Value Held $1.12 Million

Daniel H. Orenstein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 02 2021	BUY Exercise of conversion of derivative security	$25,850 $10.34 p/Share	2,500 Added 3.01%	80,546 Common Stock
Jul 01 2021	SELL Open market or private sale	$140,300 $56.12 p/Share	2,500 Reduced 3.1%	78,046 Common Stock
Jul 01 2021	BUY Exercise of conversion of derivative security	$25,850 $10.34 p/Share	2,500 Added 3.01%	80,546 Common Stock
Jun 03 2021	SELL Open market or private sale	$204,480 $52.81 p/Share	3,872 Reduced 4.73%	78,046 Common Stock
Jun 03 2021	BUY Exercise of conversion of derivative security	$25,850 $10.34 p/Share	2,500 Added 2.96%	81,918 Common Stock
Jun 01 2021	SELL Payment of exercise price or tax liability	$60,777 $53.88 p/Share	1,128 Reduced 1.4%	79,418 Common Stock
Apr 15 2021	SELL Open market or private sale	$180,460 $51.56 p/Share	3,500 Reduced 4.16%	80,546 Common Stock
Apr 15 2021	BUY Exercise of conversion of derivative security	$36,190 $10.34 p/Share	3,500 Added 4.0%	84,046 Common Stock
Mar 15 2021	SELL Open market or private sale	$170,730 $48.78 p/Share	3,500 Reduced 4.16%	80,546 Common Stock
Mar 15 2021	BUY Exercise of conversion of derivative security	$36,190 $10.34 p/Share	3,500 Added 4.0%	84,046 Common Stock
Mar 02 2021	SELL Open market or private sale	$82,875 $47.52 p/Share	1,744 Reduced 2.12%	80,546 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$37,135 $49.12 p/Share	756 Reduced 0.91%	82,290 Common Stock
Feb 18 2021	BUY Grant, award, or other acquisition	-	25,000 Added 23.14%	83,046 Common Stock
Feb 16 2021	SELL Open market or private sale	$186,165 $53.19 p/Share	3,500 Reduced 5.69%	58,046 Common Stock
Feb 16 2021	BUY Exercise of conversion of derivative security	$36,190 $10.34 p/Share	3,500 Added 5.38%	61,546 Common Stock
Jan 15 2021	SELL Open market or private sale	$167,930 $47.98 p/Share	3,500 Reduced 5.69%	58,046 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	$36,190 $10.34 p/Share	3,500 Added 5.38%	61,546 Common Stock
Jan 13 2021	SELL Open market or private sale	$471,800 $47.18 p/Share	10,000 Reduced 14.7%	58,046 Common Stock
Jan 13 2021	BUY Exercise of conversion of derivative security	$103,400 $10.34 p/Share	10,000 Added 12.81%	68,046 Common Stock
Dec 17 2020	BUY Exercise of conversion of derivative security	$289,996 $10.34 p/Share	28,046 Added 32.58%	58,046 Common Stock
Dec 15 2020	SELL Open market or private sale	$194,150 $38.83 p/Share	5,000 Reduced 14.29%	30,000 Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	$51,700 $10.34 p/Share	5,000 Added 12.5%	35,000 Common Stock
Dec 04 2020	SELL Open market or private sale	$353,115 $37.17 p/Share	9,500 Reduced 24.05%	30,000 Common Stock
Dec 04 2020	BUY Exercise of conversion of derivative security	$98,230 $10.34 p/Share	9,500 Added 19.39%	39,500 Common Stock
Dec 02 2020	SELL Open market or private sale	$138,940 $35.48 p/Share	3,916 Reduced 11.55%	30,000 Common Stock

DHO

Daniel H. Orenstein

General Counsel

South Jordan, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCAT shares.

Notify only if

Value

Insider Trading

Get notified when an Health Catalyst, Inc. insider buys or sells HCAT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Health Catalyst, Inc.

Track Activities on HCAT

Account